61.85
Cidara Therapeutics Inc Borsa (CDTX) Ultime notizie
Cidara Therapeutics Inc. Stock Analysis and ForecastHigh-profit stock alerts - PrintWeekIndia
What drives Cidara Therapeutics Inc. stock priceTriple-digit growth rates - PrintWeekIndia
What analysts say about Cidara Therapeutics Inc. stockRapid market gains - PrintWeekIndia
Will Cidara Therapeutics Inc. stock benefit from interest rate changesRapid market gains - jammulinksnews.com
Cidara Therapeutics to Report Second Quarter 2025 Financial - GlobeNewswire
Cidara Therapeutics Sets Q2 Earnings Date: Key Updates on DFC Immunotherapy Platform Expected - Stock Titan
Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025 - 富途牛牛
Is Cidara Therapeutics Inc. a good long term investmentMarket-beating returns - Autocar Professional
Cidara more than doubles on phase 2 flu preventative data - MSN
(CDTX) On The My Stocks Page - news.stocktradersdaily.com
ATAI Impresses, CDTX Navigates With Confidence, MTSR Builds Momentum, COGT Keeps Scaling The Summit… - RTTNews
Growth or Bubble? Unpacking CDTX Stock Surge - timothysykes.com
Cidara Therapeutics (CDTX) up more than 200% since Jun 20 - AInvest
Cidara Therapeutics stock hits 52-week high at 56.85 USD - Investing.com Australia
Cidara Therapeutics stock hits 52-week high at 56.85 USD By Investing.com - Investing.com Canada
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of “Buy” from Brokerages - Defense World
What makes Cidara Therapeutics Inc. stock price move sharplyWatchlist Winner Update - Newser
Why Cidara Therapeutics Inc. stock attracts strong analyst attentionConsistent Growth Alert - newser.com
Finance Watch: A Mini-Surge In Follow-On Offerings Follows Positive Updates - insights.citeline.com
Segal Trials Contributes to Breakthrough Flu Prevention Study Led by Cidara Therapeutics - Business Wire
Cidara Therapeutics announces inclusion in the Russell 2000 and 3000 indexes - MSN
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Cidara Therapeutics shares fall 5.99% after-hours following inducement grants announcement. - AInvest
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains - TradingView
hVIVO reports positive results from Cidara’s Phase 2b influenza study By Investing.com - Investing.com Canada
(CDTX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Phathom Pharmaceuticals shares rise 1.47% premarket after Cidara Therapeutics closes $402.5 million stock offering. - AInvest
Cidara Therapeutics prices upsized $350 milion stock offering at $44 - MSN
Cidara Therapeutics Advances CD388 To Phase 3, Reiterated Buy (NASDAQ:CDTX) - Seeking Alpha
Cidara Therapeutics (CDTX) Price Target Raised by RBC Capital | CDTX Stock News - GuruFocus
Cidara Therapeutics announces $250M public stock offering - MSN
Cidara stock surges as H.C. Wainwright raises price target on trial data By Investing.com - Investing.com South Africa
Cidara Therapeutics Stock Jumps After-Hours As Strong Flu Trial Data Outweighs $250M Share Offering - Stocktwits
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):